new coronavirus
Showing 1 - 25 of >10,000
COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))
Recruiting
- COVID-19
- Recombinant new coronavirus vaccine (CHO cell)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 10, 2022
Long COVID Trial in Samara (Device)
Enrolling by invitation
- Long COVID
- Device
-
Samara, Pestravka, Russian FederationDanija
Apr 16, 2023
COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))
Recruiting
- COVID-19
- Recombinant new coronavirus vaccine (CHO cell)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 2, 2023
New Coronavirus Vaccination for Couples During Peri-pregnancy
Recruiting
- Perinatal
- New crown vaccine
-
Beijing, Beijing, ChinaBeijing Ditan Hospital, Capital Medical University
Nov 8, 2021
Coronavirus Disease 2019 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell) group)
Completed
- Coronavirus Disease 2019
- Recombinant new coronavirus vaccine (CHO cell) group
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 21, 2021
Coronavirus Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell) group, Recombinant new coronavirus vaccine (CHO
Recruiting
- Coronavirus
- Recombinant new coronavirus vaccine (CHO cell) group
- Recombinant new coronavirus vaccine (CHO cells) placebo group
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jul 19, 2021
Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)
Enrolling by invitation
- Corona Virus Disease 2019(COVID-19)
- 0.3ml of mRNA vaccine
-
Chengdu, ChinaWest China Second University Hospital
Oct 3, 2022
New Immune-inflammation Index for Predicting Prognosis of
Completed
- Covid19
- +2 more
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Coronavirus Disease 2019 Trial in Changsha (Tetravalent influenza virus lysis vaccine, Recombinant new coronavirus vaccine (CHO
Recruiting
- Coronavirus Disease 2019
- Tetravalent influenza virus lysis vaccine
- Recombinant new coronavirus vaccine (CHO cell) group
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Nov 3, 2021
Coronavirus Disease Trial in Princeton
Completed
- Coronavirus Disease
-
Princeton, New JerseyGlobal Clinical Trials, LLC,
Mar 2, 2023
Dexamethasone and COVID-19 Inpatient Mortality
Completed
- Coronavirus
- Dexamethasone Oral
-
New York, New YorkAetion, Inc.
Dec 7, 2022
COVID-19 Vaccine Trial in Ciudad Autónoma de Buenos Aires (ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2))
Active, not recruiting
- COVID-19 Vaccine
- ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
-
Ciudad Autónoma de Buenos Aires, ArgentinaUnidad de Investigación Clínica Farmacocinética FP Clinical Phar
Dec 21, 2022
Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))
Completed
- Coronavirus Disease 2019
- Placebo
- Leronlimab (700mg)
-
Los Angeles, California
- +11 more
Dec 8, 2022
Acquiring Convalescent Specimens for COVID-19 Antibodies
Completed
- COVID-19
- +2 more
- Blood draw
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jul 18, 2022
Healthy Trial in New York, Irving (Stress First Aid)
Recruiting
- Healthy
- Stress First Aid
-
New York, New York
- +1 more
Oct 24, 2022
COVID-19 and Working Conditions of Dentists
Completed
- COVID-19
- Dentistry
- No intervention
-
Istanbul, TurkeyIstanbul University, Faculty of Dentistry
Jan 4, 2022
Coronavirus Trial in Xiangtan (Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group,
Unknown status
- Coronavirus
- Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group
- +2 more
-
Xiangtan, Changsha, ChinaHunan Provincial Center for Disease Control and Prevention
Jan 26, 2021
Tachycardia, Dyspnea, COVID-19 Trial in Hackensack (Metoprolol Succinate)
Recruiting
- Tachycardia
- +2 more
- Metoprolol Succinate
-
Hackensack, New JerseyHackensack Univeristy Medical Center
Dec 13, 2022
SARS-CoV Infection, Covid19 Trial in New Brunswick (Nitazoxanide, Placebo Nitazoxanide, Ribavirin)
Terminated
- SARS-CoV Infection
- Covid19
- Nitazoxanide
- +5 more
-
New Brunswick, New JerseyRobert Wood Johnson Medical School
May 3, 2022
COVID-19 Vaccines and the Development of New LUTS
Completed
- COVID-19 Vaccine Adverse Reaction
- Lower Urinary Tract Symptoms
-
Zarqa, JordanThe Hashemite University
Oct 14, 2022
Coronavirus Infection Trial in São Carlos (Ivermectin, Standard of Care)
Terminated
- Coronavirus Infection
- Ivermectin
- Standard of Care
-
São Carlos, São Paulo, Brazil
- +1 more
Oct 7, 2021
Covid-19, Coronavirus Infection, Coronavirus Trial in New York (COVID-19 Serology, Health Care Worker Survey)
Recruiting
- Covid-19
- +2 more
- COVID-19 Serology
- Health Care Worker Survey
-
New York, New YorkNewYork-Presbyterian Hosptial/Columbia University Irving Medical
Apr 4, 2022
COVID-19 Patients - The Coronavirus Related Outpatient Work
Completed
- Covid-19 (SARS-CoV-2)
-
New Hyde Park, New York410 Lakeville Road, Suite 107
Jul 13, 2022
ImmuneSense™ COVID-19 Study
Completed
- Coronavirus Disease (COVID-19)
- SARS-CoV-2 Infection
- T-Detect™ SARS-CoV-2 Assay
-
Secaucus, New JerseyAdaptive Biotechnologies Clinical Investigational Site
Apr 13, 2022
Cardiac Arrhythmias In Coronavirus Disease (COVID-19)
Recruiting
- COVID 19 Cardiac
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Apr 11, 2022